Septic Shock Treatment With Special Kidney-Filter Devices
Part of Infections clinical trials.
This study looks back at how a special kidney filter called oXiris helped patients in the ICU who had septic shock (a life-threatening blood infection) and kidney failure. Researchers want to understand if this filter improved survival and recovery compared to standard treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years old or older
- You were admitted to an intensive care unit (ICU) with septic shock—a severe infection causing organ stress—between March 2021 and August 2025
- Your kidneys stopped working suddenly (acute kidney injury), and you needed continuous kidney-support treatment called CRRT
- You did not die or stop life support within the first 48 hours of ICU admission
- You do not have end-stage renal disease (long-term permanent kidney failure from chronic disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether using a special filter (oXiris) during dialysis can better remove harmful toxins from the blood in people with septic shock and kidney failure, potentially helping them recover faster.
This trial tests a special blood filtering device (OXiris) in patients with severe abdominal infections and septic shock. The filter may help remove harmful substances from the blood and support kidney function, potentially improving recovery.
This study tests a special blood-filtering treatment (called Oxiris) for people with septic shock, a life-threatening condition where infection causes very low blood pressure. The goal is to see if this treatment can safely improve recovery. If you are already receiving CRRT, this may help your blood get cleaner and your pressure more stable.
This trial tests whether a special type of dialysis filter (oXiris) helps reduce blood clotting problems in patients with septic shock and kidney failure. It may offer a better option for those needing kidney support in the ICU.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial tests a blood-filtering device (CytoSorb) that may help control the overwhelming immune response and improve blood vessel function in people with severe septic shock. It's for patients who need strong medications to keep their blood pressure up and who haven't improved with standard care.
Hear when a new Septic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.